FDA approves cheaper Botox rival to treat frown lines

FILE PHOTO: A vial of Botox and a syringe are seen in Athens, Greece December 12, 2017. REUTERS/Costas Baltas REUTERS/Mike Segar

(Reuters) – An injection to treat forehead wrinkles is set to rival Allergan’s Botox after U.S. regulators approved Evolus Inc’s cheaper treatment on Friday, sending its shares up about 5 percent after the bell. The approval of Evolus’s Jeuveau to treat frown lines comes about eight months after the agency declined to approve the drug, […]

Continue reading this article with a Fiji Times online membership.

More Stories